Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |